AVVAA World Healthcare Products, Inc.   Report issue

For profit Phase 2
Founded: Richmond VA United States (1998)
Status: Left NME R&D (2005)

Organization Overview

First Clinical Trial
2005
NCT00143819
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

benzyl alcohol (ulesfia) (1 trial)

nifedipine (procardia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Eczema (Phase 2)

Psoriasis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2